Thyroid dysfunction can have many manifestations, etiologies, and widespread implications for body metabolism and overall health. Thyroid gland inflammation (thyroiditis) can occur for many different reasons and is often the result of an autoimmune thyroid disorder. Early and accurate diagnosis of potential autoimmune thyroid dysfunction is essential when determining treatment plans. Effectively monitoring and managing autoimmune symptoms can avoid further health complications and help your patients achieve their health goals.
Our Comprehensive Thyroid Panel contains the thyroid antibody biomarkers needed for the diagnosis, monitoring, and management of a variety of autoimmune thyroid disorders such as Hashimoto’s disease, autoimmune thyroiditis, and Graves’ Disease.
US BioTek runs our Thyroid Panels on a sophisticated FDA-approved Roche enzyme-amplified chemiluminescence platform (CLA) to detect even exceptionally small variations in thyroid function. The CLA technique features higher sensitivity than conventional ELISA and was purposely selected based on our 30+ years of experience in immunoassay development. We are confident this process provides the most accurate results.